A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

Clinical trial NCT01475825 · COMPLETED

Trial details

NCT number: NCT01475825
Sponsor: Kastle Therapeutics, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia Heterozygous Familial

Start date: 2011-12-01
Primary completion: 2015-12-29
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.